We know that controlling risk factors for type 2 diabetes reduces the risk for Alzheimer's disease, but why? Some interesting research from South Korea may provide new insight. The research was described in a recent article in the ALZForum, "Stress-Associated Protein Modulates γ-Secretase to Make More Aβ." What's that about?
In order to advance from the 10th to the 11th grade in Washington State public schools, you're required to know that the endoplasmic reticulum (ER) is a component part of most cells in the body, and it synthesizes lipids and cholesterol. The ER is an organelle (sort of like an organ of the cell) and is a structure made up of various proteins. This is one piece of the puzzle.
In diabetes there is excess glucose running around in the blood stream. The excess glucose is destructive and causes a form of stress for the cells. Another piece of the puzzle.
Beta amyloid is a malformed protein that is characteristic of Alzheimer's disease. It is formed when the "amyloid precursor protein" (APP) is cut by, among other things, the γ-secretase protein. (No one knows what the purpose of APP is, but it sure plays a big role when things go bad in the brain.) Apparently, changes in γ-secretase activity can vary the production of beta amyloid by doing more APP cutting. This implies that varying the amount of γ-secretase can affect the advance of Alzheimer's disease. Still another piece of the puzzle.
There is a protein called "the stress-associated ER protein 1" (SERP1) located on the surface of the ER. It promotes γ-secretase activity which results in more APP cutting and, therefore, more beta amyloid generation. Another puzzle piece.
SERP1 responds to stress from excess glucose -- a condition occurring in diabetes -- and prompts the generation of more γ-secretase and therefore more APP cutting and the generation of more beta amyloid. And so the excess blood glucose in diabetes can promote Alzheimer's disease. (This may be a serious over-simplification, but I think it's a reasonable overview.)
Well, anyway, that's the hypothesis. So how can this hypothesis be tested -- as we must inevitably do? For this, the researchers did a number of things, but one was to review the autopsy findings of normal brains and people who died with Alzheimer's disease. One finding was that the hippocampi in diseased brains contained ten times the SERP1 as in the normal brains. This was one of several confirmatory research findings.
The completed puzzle: Excess glucose in diabetes causes cellular stress. The stress stimulates the SERP1 protein, which encourages γ-secretase activity. γ-secretase activity results in more APP cutting and the generation of more beta amyloid. More beta amyloid means that Alzheimer's disease progresses.
The bottom line? Control your risk factors for type 2 diabetes! Eat right and get plenty of exercise! (Of course, you must always manage any type of diabetes in accordance with your physician's direction.)
In my book, "Beating the Dementia Monster," I describe what has occurred since 2015 when I first knew I had memory problems. (You can find it on Amazon.com.) I have experienced remarkable improvement, and I’m certain that I can share valuable information with many others. In this second edition I continue my story to 2020 and provide greater understanding of how Alzheimer's advances and why what I did worked.
Subscribe to:
Post Comments (Atom)
And it gets worse ... or does it?
I've remarked before that, when I speak on the diet aspects of the Dementia Toolkit, I hear groans ... notably, when I talk about avoidi...
-
We know that controlling risk factors for type 2 diabetes reduces the risk for Alzheimer's disease, but why? Some interesting research ...
-
Back in 2019, we wrote about a journal article on a phenomenon called " paradoxical lucidity. " What is that? It's the obse...
-
In 2012, the Nobel Prize in Physiology or Medicine was awarded to John B. Gurdon and Shinya Yamanaka for their discovery that essentially an...
No comments:
Post a Comment